Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
A 65-year-old female presented with visual disturbance in her right eye lasting for over 2 months. Following investigations, she was diagnosed with MacTel type 1 in the right eye. Visual symptoms were refractory to initial treatment with intravitreal bevacizumab and thereafter intravtireal triamicin...
Saved in:
Main Authors: | Mohamed Loutfi, Thomas Papathomas, Ahmed Kamal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/231913 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
by: O’Sam Shibeeb, et al.
Published: (2014-01-01) -
A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
by: Erdem Eris, et al.
Published: (2017-01-01) -
Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
by: Dominik Zalewski, et al.
Published: (2014-01-01) -
Unusual Presentation of Type 1 Idiopathic Macular Telangiectasia
by: Zaïnab Bentaleb Machkour, et al.
Published: (2017-01-01) -
Intravitreal dexamethasone implant (Ozurdex®) findings over time: ultrasound and ultra-widefield fundus photography
by: Gabriela Assumpção Brito Pereira Pellegrini, et al.
Published: (2025-01-01)